BRAF and follicular variant thyroid gland papillary carcinoma: Hence, a strong co-expression of HBME-1 and galectin-3 along with BRAF V600E expression can differentiate FAs from FVPTC (p < 0.001), especially if papillary features are focal and difficult [18].